← Leaderboards
Mary J Roman
Weill Medical College Of Cornell Univ
$1,234,609
Attributed
$1,234,609
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,234,609 · 2
By mechanism
R01$1,169,463 · 1
M01$65,146 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Aaron J. Marcus$14,028,570
- Thomas G Pickering$3,616,415
- Roy L Silverstein$14,739,965
- Jorge R Kizer$10,067,369
- David P Hajjar$13,911,032
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisBiomarkerClinical ResearchHuman SubjectInflammationSystemic Lupus ErythematosusComorbidityDisease /Disorder Proneness /RiskVentricular HypertrophyMyocardial InfarctionCardiovascular Disorder EpidemiologyCd40 MoleculeThrombosisCardiovascular Disorder RiskMyocardium DisorderDisease /Disorder EtiologyPathologic ProcessEpidemiologyPatient Oriented ResearchImmune Response
Grant awards (6)
ACCELERATED ATHEROSCLEROSIS IN SLE: PREVALENCE AND MECHANISMS$12,390
M01 · FY2005 · RR
Accelerated atherosclerosis in SLE: Prevalence and mechanisms$52,756
M01 · FY2004 · RR
ACCELERATED ATHEROSCLEROSIS IN SLE--PREVALENCE/FACTORS$295,366
R01 · FY2003 · AR
ACCELERATED ATHEROSCLEROSIS IN SLE--PREVALENCE/FACTORS$297,364
R01 · FY2002 · AR
ACCELERATED ATHEROSCLEROSIS IN SLE--PREVALENCE/FACTORS$291,308
R01 · FY2001 · AR
ACCELERATED ATHEROSCLEROSIS IN SLE--PREVALENCE/FACTORS$285,425
R01 · FY2000 · AR